Surgical Endoscopy

, Volume 28, Issue 5, pp 1500–1504 | Cite as

Medically refractory gastroesophageal reflux disease in the obese: what is the best surgical approach?

  • Maurice-Pierre Pagé
  • Andrew Kastenmeier
  • Matthew Goldblatt
  • Matthew Frelich
  • Matthew Bosler
  • James Wallace
  • Jon Gould



Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be appropriate in the morbidly obese, especially when other effective alternatives exist (bariatric surgery).


A 13-item survey was designed to elicit professional opinions regarding the treatment of medically refractory GERD in obese patients. Members of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) were randomly selected and emailed a link to an online survey.


A total of 550 surgeons were contacted via email, and 92 (17 %) completed the survey. Of the respondents, 88 % perform laparoscopic antireflux surgery, 63 % perform bariatric surgery, and 59 % perform both. Overall, 77 % completed a minimally invasive surgery fellowship. In response to the question “Would you perform a laparoscopic fundoplication in a patient with medically refractory GERD and a BMI of ‘X’?” surgeons were less likely to offer fundoplication at a higher body mass index (BMI). The majority of respondents felt that laparoscopic Roux-en-Y gastric bypass was the best option (91 %), followed by laparoscopic sleeve gastrectomy (6 %). Many had a morbidly obese patient with a primary surgical indication of GERD denied a bariatric procedure by their insurance company (57 %), and 35 % of those surgeons chose to do nothing rather than subject the patient to a fundoplication. Respondents uniformly felt that bariatric surgery should be recognized as a standard surgical option for treating GERD in the obese (96 %).


When surgical treatment of GERD is indicated in an obese patient, bariatric surgery is the optimal approach, in the opinion of surgeons responding to our survey. Unfortunately, third-party payers often decline to provide benefits for a bariatric procedure for this indication. Additional data is necessary to confirm our belief that the opinions elicited through this survey are consistent with the standard of care as defined by the medical community.


Fundoplication Morbid obesity GERD Survey Gastric bypass 



Drs. Pagé, Kastenmeier, Goldblatt, Wallace, and Gould, Matthew Frelich, and Matthew Bosler have no conflicts of interest or financial ties to disclose.


  1. 1.
    Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497PubMedCrossRefGoogle Scholar
  2. 2.
    Hampel H, Abraham NS, El-Serag HB (2005) Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143(3):199–211PubMedCrossRefGoogle Scholar
  3. 3.
    Madalosso CA, Gurski RR, Callegari-Jacques SM, Navarini D, Thiesen V, Fornari F (2010) The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus. Ann Surg 251(2):244–248PubMedCrossRefGoogle Scholar
  4. 4.
    Mejía-Rivas MA, Herrera-López A, Hernández-Calleros J, Herrera MF, Valdovinos MA (2008) Gastroesophageal reflux disease in morbid obesity: the effect of Roux-en-Y gastric bypass. Obes Surg 18(10):1217–1224PubMedCrossRefGoogle Scholar
  5. 5.
    Shaheen N, Provenzale D (2003) The epidemiology of gastroesophageal reflux disease. Am J Med Sci 326:264–273PubMedCrossRefGoogle Scholar
  6. 6.
    Grant AM, Boachie C, Cotton SC, Faria R, Bojke L, Epstein DM, Ramsay CR, Corbacho B, Sculpher M, Krukowski ZH, Heading RC, Campbell MK, REFLUX trial group (2013) Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial). Health Technol Assess 17(22):1–167PubMedGoogle Scholar
  7. 7.
    Colquitt JL, Picot J, Loveman E, Clegg AJ (2009) Surgery for obesity. Cochrane Database Syst Rev 15(2):CD003641Google Scholar
  8. 8.
    Morgenthal C, Lin E, Shane M, Hunter JG, Smith CD (2007) Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc 21(11):1978–1984PubMedCrossRefGoogle Scholar
  9. 9.
    Frezza EE, Ikrasmuddin S, Gourash W, Rakitt T, Kingston A, Luketich J, Schauer PR (2002) Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 16:1027–1031PubMedCrossRefGoogle Scholar
  10. 10.
    Perez AR, Moncure AC, Rattner DW (2001) Obesity adversely affects the outcome of antireflux operations. Surg Endosc 15:986–989PubMedCrossRefGoogle Scholar
  11. 11.
    Hahnloser D, Schumacher M, Calvin R, Cosendey B, Petropoulos P (2002) Risk factors for complications of laparoscopic Nissen fundoplication. Surg Endosc 16:43–47PubMedCrossRefGoogle Scholar
  12. 12.
    Anvari M, Bamehriz F (2006) Outcome of laparoscopic Nissen fundoplication in patients with body mass index ≥35. Surg Endosc 20(2):230–234PubMedCrossRefGoogle Scholar
  13. 13.
    Winslow ER, Frisella MM, Soper NJ, Klingensmith ME (2003) Obesity does not adversely affect the outcome of laparoscopic antireflux surgery (LARS). Surg Endosc 17:2003–2011PubMedCrossRefGoogle Scholar
  14. 14.
    Chisholm JA, Jamieson GG, Lally CJ, Devitt PG, Game PA, Watson DI (2009) The effect of obesity on the outcome of laparoscopic antireflux surgery. J Gastrointest Surg 13(6):1064–1070PubMedCrossRefGoogle Scholar
  15. 15.
    Awais O, Luketich JD, Schuchert MJ, Morse CR, Wilson J, Gooding WE, Landreneau RJ, Pennathur A (2011) Reoperative antireflux surgery for failed fundoplication: an analysis of outcomes in 275 patients. Ann Thorac Surg 92(3):1083–1089PubMedCrossRefGoogle Scholar
  16. 16.
    Musunuru S, Gould JC (2012) Perioperative outcomes of surgical procedures for symptomatic fundoplication failure: a retrospective case-control study. Surg Endosc 26:838–842PubMedCrossRefGoogle Scholar
  17. 17.
    Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ (2006) Obesity: a challenge to esophagogastric junction integrity. Gastroenterol 130:639–649CrossRefGoogle Scholar
  18. 18.
    Sugerman HJ (2001) Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am 81(5):1063–2001PubMedCrossRefGoogle Scholar
  19. 19.
    Fornari F, Madalosso CA, Farré R, Gurski RR, Thiesen V, Callegari-Jacquese SM (2010) The role of gastro-oesophageal pressure gradient and sliding hiatal hernia on pathological gastro-oesophageal reflux in severely obese patients. Eur J Gastroenterol Hepatol 22:404–411PubMedCrossRefGoogle Scholar
  20. 20.
    El-Serag HB, Graham DY, Satia JA, Rabeneck L (2005) Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 100:1243–1250PubMedCrossRefGoogle Scholar
  21. 21.
    Jones KB (1998) Roux-en-Y gastric bypass: an effective antireflux procedure in the less than morbidly obese. Obes Surg 8:35–38PubMedCrossRefGoogle Scholar
  22. 22.
    Tutuian R (2011) Obesity and GERD: pathophysiology and effect of bariatric surgery. Curr Gastroenterol Rep 13(3):205–212PubMedCrossRefGoogle Scholar
  23. 23.
    Chiu S, Birch DW, Shi X, Sharma AM, Karmali S (2011) Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis 7(4):510–515PubMedCrossRefGoogle Scholar
  24. 24.
    Iovino P, Angrisani L, Tremolaterra F, Nirchio E, Ciannella M, Borrelli V, Sabbatini F, Mazzacca G, Ciacci C (2002) Abnormal esophageal acid exposure is common in morbidly obese patients and improves after a successful Lap-band system implantation. Surg Endosc 16:1631–1635PubMedCrossRefGoogle Scholar
  25. 25.
    Klaus A, Gruber I, Wetscher G, Nehoda H, Aigner F, Peer R, Margreiter R, Weiss H (2006) Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding. Arch Surg 141:247–251PubMedCrossRefGoogle Scholar
  26. 26.
    Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292(14):1724–1737PubMedCrossRefGoogle Scholar
  27. 27.
    Varela JE, Hinojosa MW, Nguyen NT (2009) Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease. Surg Obes Relat Dis 5:139–143PubMedCrossRefGoogle Scholar
  28. 28.
    Al Harakeh AB, Burkhamer KJ, Kallies KJ, Mathiason MA, Kothari SN (2010) Natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery. Surg Obes Relat Dis 6(6):591–596PubMedCrossRefGoogle Scholar
  29. 29.
    Ibele A, Garren M, Gould J (2012) The impact of previous fundoplication on laparoscopic gastric bypass outcomes: a case-control evaluation. Surg Endosc 26(1):177–181PubMedCrossRefGoogle Scholar
  30. 30.
    Reavis KM (2011) Management of the obese patient with gastroesophageal reflux disease. Thorac Surg Clin 21(4):489–498PubMedCrossRefGoogle Scholar
  31. 31.
    Vivek N, Prachand VN, Alverdy JC (2010) Gastroesophageal reflux disease and severe obesity: fundoplication or bariatric surgery? World J Gastroenterol 16(30):3757–3761CrossRefGoogle Scholar
  32. 32.
    Gould J, Ellsmere J, Fanelli R, Hutter M, Jones S, Pratt J, Schauer P, Schirmer B, Schwaitzberg S, Jones DB (2011) Panel report: best practices for the surgical treatment of obesity. Surg Endosc 25(6):1730–1740PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Maurice-Pierre Pagé
    • 1
  • Andrew Kastenmeier
    • 1
  • Matthew Goldblatt
    • 1
  • Matthew Frelich
    • 1
  • Matthew Bosler
    • 1
  • James Wallace
    • 1
  • Jon Gould
    • 1
  1. 1.Department of Surgery, Division of General SurgeryMedical College of WisconsinMilwaukeeUSA

Personalised recommendations